12-10909113-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_023920.2(TAS2R13):āc.186A>Gā(p.Ile62Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,613,782 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_023920.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS2R13 | NM_023920.2 | c.186A>G | p.Ile62Met | missense_variant | 1/1 | ENST00000390677.2 | NP_076409.1 | |
PRH1 | NM_001291315.2 | c.104-26017A>G | intron_variant | NP_001278244.1 | ||||
PRH1 | NM_001291314.2 | c.-58-24838A>G | intron_variant | NP_001278243.1 | ||||
PRH1-PRR4 | NR_037918.2 | n.545-24838A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R13 | ENST00000390677.2 | c.186A>G | p.Ile62Met | missense_variant | 1/1 | 6 | NM_023920.2 | ENSP00000375095.2 | ||
ENSG00000275778 | ENST00000703543.1 | c.-58-24838A>G | intron_variant | ENSP00000515364.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 249966Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135140
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1461460Hom.: 0 Cov.: 33 AF XY: 0.00000413 AC XY: 3AN XY: 727012
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152322Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74490
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 17, 2023 | The c.186A>G (p.I62M) alteration is located in exon 1 (coding exon 1) of the TAS2R13 gene. This alteration results from a A to G substitution at nucleotide position 186, causing the isoleucine (I) at amino acid position 62 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at